AB521

· Arcus Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for AB521, covering 2024-10-17 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors [Phase 1]

See pricing